Modulation of biological regulatory networks during nephrogenesis

Drug Metabolism Reviews

Volumn 38, Issue 4, 2006, Pages 677-683

  Ramos, Kenneth S ^a,b   Hadi Falahatpisheh, M ^a   Nanez, Adrian ^a   He, Qiang ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

Ahr; Nephrogenesis; Wt1

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; POLYCYCLIC AROMATIC HYDROCARBON;

CELL DIFFERENTIATION; CELL STRUCTURE; CONFERENCE PAPER; DOWN REGULATION; GENETIC REGULATION; KIDNEY CELL; KIDNEY DEVELOPMENT; MESENCHYME; MODULATION; MOLECULAR INTERACTION; NEPHRON; NONHUMAN; ORGANOGENESIS; SUPPRESSOR GENE; WILMS TUMOR SUPPRESSOR GENE;

ANIMALS; EPITHELIAL CELLS; FEMALE; GENES, WILMS TUMOR; HUMANS; KIDNEY; MESENCHYMAL STEM CELLS; NEPHRONS; PREGNANCY; RECEPTORS, ARYL HYDROCARBON;

EID: 33845383892     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.1080/03602530600959532     Document Type: Conference Paper

References (33)

1. Abbott, B. D., Perdew, G. H., Buckalew, A. R., Birnbaum, L.S. (1994). Interactive regulation of Ah and glucocorticoid receptors in the synergistic induction of cleft palate by 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone. Toxicol. Appl. Pharmacol. 128(1):138-150.
2. Andreola, F., Fernandez-Salguero, P. M., Chiantore, M. V., Petkovich, M. P., Gonzalez, F. J., De Luca, L. M. (1997). Aryl hydrocarbon receptor knockout mice (AHR-/-) exhibit liver retinoid accumulation and reduced retinoic acid metabolism. Cancer Res. 57(14):2835-2838.
3. Baudry, D., Faussillon, M., Cabanis, M. O., Rigolet, M., Zucker, J. M., Patte, C., Sarnacki, S., Boccon-Gibod, L., Junien, C., Jeanpierre, C. (2002). Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour. Oncogene 21(36):5566-5573.
4. Chellaiah, M. A., Kizer, N., Biswas, R., Alvarez, U., Strauss-Shoenberger, J., Rifas, L., Rittling, S. R., Denhardt, D. T., Hruska, K. A. (2003). Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol. Biol. Cell 14(1):173-189.
5. Dailly, Y. P., Zhou, Y., Linkhar, T. A., Baylink, D. J., Strong, D. D. (2001). Structure and characterization of the human insulin-like growth factor binding protein (IGFBP)-6 promoter: identification of a functional retinoid response element. Biochim. Biophys. Acta (BBA) - Gene Structure and Expression 1518(1-2):145-151.
6. Duong Van Huyen, J. P., Amri, K., Baclair, M. F., Vilar, J., Merlet-Bacnichou, C., Bruneval, P., Leliavre-Pacgorier, M. (2003). Spatiotemporal distribution of insulin-like growth factor receptors during nephrogenesis in fetuses from normal and diabetic rats. Cell Tissue Res. 314(3):367-379.
7. Englert, C., Maheswaran, S., Garvin, A. J., Kreidberg, J., Haber, D. A. (1997). Induction of p21 by the Wilms' tumor suppressor gene WT1. Cancer Res. 57(8):1429-1434.
8. Falahatpisheh, M. H., Ramos K. S. (2003). Ligand-activated Ahr signaling leads to disruption of nephrogenesis and altered Wilms' tumor suppressor mRNA splicing. Oncogene 22(14):2160-2171.
9. Falahatpisheh, M. H., Ramos, K. S. (2006). Ahr transcription factor regulates Wt1 at the posttranscriptional level and plays a role in nephrogenesis (in preparation).
10. Gonzalez, F. J., Fernandez-Salguero, P. (1998). The aryl hydrocarbon receptor. Studies using the Ahr-null mice. Drug Metab. Dispos. 26(12):1194-1198.
11. Hewitt, S. M., Saunders, G. F. (1996). Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function. Anticancer Res. 16(2):621-626.
12. Hosono, S., Luo, X., Hyink, D. P., Schnapp, L. M., Wilson, P. D., Burrow, C. R., Reddy, J. C., Atweh, G. F., Licht, J. D. (1999). WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts. Oncogene 18:417-427.
13. Ito, K., Oji, Y., Tatsumi, N., Shimizu, S., Kanai, Y., Nakazawa, T., Asada, M., Jomgeow, T., Aoyagi, S., Nakano, Y., Tamaki, H., Sakaguchi, N., Shirakata, T., Nishida, S., Kawakami, M., Tsuboi, A., Oka, Y., Tsujimoto, Y., Sugiyama, H.. (2006). Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway. Oncogene 25(30):4217-4229.
14. Johnson, C. D., Balagurunathan, Y., Tadesse, M. G., Falahatpisheh, M. H. Brun, M., Walker, K. M., Dougherty, E. R., Ramos, K. S. (2004).Unraveling gene-gene interactions regulated by ligands of the aryl hydrocarbon receptor. Envir. Health Persp. 112(4):403-412.
15. Kerkvliet, N. I., Shepherd, D. M., Baecher-Steppan, L. (2002). T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD. Toxicol. Appl. Pharmacol. 185(2):146-152.
16. Kreidberg, J. A., Sariola, H., Loring, J. M., Maeda, M., Pelletier, J., Housman, D., Jaenisch, R. (1993). Wt1 is required for early kidney development. Cell 74:679-691.
17. Kuure, S., Vuolteenaho, R., Vainio, S. (2000). Kidney morphogenesis: cellular and molecular regulation. Mech. of Develop. 92(1):31-45.
18. Mao, M., Yu, M., Tong, J., Ye, J., Zhu, J., Huang, Q., Fu, G., Yu, L., Zhao, S., Waxman, S., Lanotte, M., Wang, Z., Tan, C. C., Tan, J., Chan, S., Chen, Z. (1996). RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell. PNAS 93(12):5910-5914.
19. Mimura, J., Fujii-Kuriyama, Y. (2003). Functional role of AhR in the expression of toxic effects by TCDD. Biochim. Biophys. Acta (BBA) - General Subjects 1619(3):263-268.
20. Mimura, J., Yamashita, K., Nakamura, K., Morita, M., Takagi, T. N., Nakao, K., Ema, M., Sogawa, K., Yasuda, M., Katsuki, M., Fujii-Kuriyama, Y. (1997). Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 2(10):645-654.
21. Murata, Y., Kudoh, T., Sugiyama, H., Toyoshima, K., Akiyama, T. (1997). The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells. FEBS Lett. 409(1):41-45.
22. Patterson, L. T., Dressler, G. R. (1994). The regulation of kidney development: New insights from and old model. Curr. Opin. Gene.t Dev. 4:696-702.
23. Puga, A., Tomlinson, C. R., Xia, Y. (2005). Ah receptor signals cross-talk with multiple developmental pathways. Biochem. Pharmacol. 69(2):199-207.
24. Rigolet, M., Faussillon, M., Baudry, D., Junien, C., Jeanpierre, C. (2001). Profiling of differential gene expression in Wilms' tumor by cDNA expression array. Ped. Nephrol. 16(12):1113-1121.
25. Scharnhorst, V., van der Eb, A. J., Jochemsen, A.G. (2001). WT1 proteins: functions in growth and differentiation. Gene 273(2):141-161.
26. Schedlich, L. J., Graham, L. D. (2002). Role of insulin-like growth factor binding protein-3 in breast cancer cell growth. Micro. Res. and Tech. 59(1):12-22.
27. Schmidt, J. V., Su, G. H.-T., Reddy, J. K., Simon, M. C., Bradfield, C. A. (1996). Characterization of a murine Ahr null allele: Involvement of the Ah receptor in hepatic growth and development. PNAS 93(13):6731-6736.
28. Singh, S. U., Casper, R. F., Fritz, P. C., Sukhu, B., Ganss, B., Girard, B. Jr., Savouret, J. F., Tenenbaum, H. C. (2000). Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol. J. Endocrinol. 167(1):183-195.
29. Sodek, J., Zhu, B., Huyng, M. H., Brown, T. J., Ringuette, M. (2002) Novel functions of the matricellular proteins osteopontin and osteonectin/SPARC. Connect. Tissue Res. 43(2-3):308-319.
30. Soprano, D. R., Soprano, K. J. (2003). Pharmacological doses of some synthetic retinoids can modulate both the aryl hydrocarbon receptor and retinoid receptor pathways. J. Nutr. 133(1):277S-281.
31. Wagner, K. D., Wagner, N., Schedl, A. (2003). The complex life of WT1. J. Cell Sci. 116(9):1653-1658.
32. Werner, H., Roberts, C. T., Rauscher, F. J., LeRoith, D. (1996). Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1. J. Mol. Neurosci. 7(2):111-123.
33. Zhang, X., Xing, G., Saunders, G. F. (1999). Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1. Anticancer Res. 19(3A):1641-1648.